{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:38:10Z","timestamp":1783111090539,"version":"3.54.6"},"reference-count":50,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["febs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["FEBS Open Bio"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>\n                    Prostate cancer (PCa) is one of the most common cancers in men, and for patients with PCa that cannot be surgically resected or treated, androgen suppression therapy often results in significant adverse effects. Recent studies have shown that A3 adenosine receptors (A\n                    <jats:sub>3<\/jats:sub>\n                    ARs) are overexpressed in prostate cancer (PCa), and several A\n                    <jats:sub>3<\/jats:sub>\n                    AR agonists and antagonists have been investigated as potential anticancer drugs. In this study, we investigated the potential therapeutic effects of the A\n                    <jats:sub>3<\/jats:sub>\n                    AR antagonists AR 292 and AR 357 in human PCa cell lines. LNCaP, DU\u2010145, and PC3 cell lines were treated with AR 292 and AR 357 compounds, and their cytotoxic effects were determined using viability assays, flow cytometry, and western blotting. Moreover, the drug transporter gene profile was evaluated using RT\u2010PCR in untreated and A\n                    <jats:sub>3<\/jats:sub>\n                    AR antagonist\u2010treated PCa cells. Both AR 292 and AR 357 showed antiproliferative effects with significant cell cycle arrest and induced DNA damage leading to cell death. AR 292 and especially AR 357 modulated the expression of drug transporter genes involved in chemoresistance, ferroptosis, and the hypoxia response. Ferroptosis was induced in DU\u2010145 cells treated with both compounds as well as in PC3 cells treated with AR 357. However, the treatment of PC3 cells with AR 292 and the treatment of LNCaP cells with both AR 292 and AR 357 resulted in necrotic cell death. In conclusion, our study showed that A\n                    <jats:sub>3<\/jats:sub>\n                    AR ligands exert anticancer effects via different mechanisms on PCa cell lines through the activation of multiple molecular pathways.\n                  <\/jats:p>","DOI":"10.1002\/2211-5463.70024","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T05:26:56Z","timestamp":1743830816000},"page":"1159-1175","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adenosine\n                    <scp>\n                      A\n                      <sub>3<\/sub>\n                    <\/scp>\n                    receptor antagonists as anti\u2010tumor treatment in human prostate cancer: an\n                    <i>in vitro<\/i>\n                    study"],"prefix":"10.1002","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-5649","authenticated-orcid":false,"given":"Maria Beatrice","family":"Morelli","sequence":"first","affiliation":[{"name":"Experimental Medicine Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Spinaci","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Chang","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Volpini","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catia","family":"Lambertucci","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Landriscina","sequence":"additional","affiliation":[{"name":"Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences \u2013 Ospedali Riuniti University of Foggia  Foggia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Conteduca","sequence":"additional","affiliation":[{"name":"Unit of Medical Oncology and Biomolecular Therapy, Department of Medical and Surgical Sciences \u2013 Ospedali Riuniti University of Foggia  Foggia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Amantini","sequence":"additional","affiliation":[{"name":"School of Bioscience and Veterinary Medicine University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Aguzzi","sequence":"additional","affiliation":[{"name":"Experimental Medicine Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Zeppa","sequence":"additional","affiliation":[{"name":"School of Bioscience and Veterinary Medicine University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Giangrossi","sequence":"additional","affiliation":[{"name":"Experimental Medicine Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Soverchia","sequence":"additional","affiliation":[{"name":"Experimental Medicine Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Santoni","sequence":"additional","affiliation":[{"name":"Oncology Unit Macerata Hospital  Macerata Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Nabissi","sequence":"additional","affiliation":[{"name":"Experimental Medicine Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Santoni","sequence":"additional","affiliation":[{"name":"Experimental Medicine Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6946-8638","authenticated-orcid":false,"given":"Carlo","family":"Polidori","sequence":"additional","affiliation":[{"name":"Experimental Medicine Unit School of Pharmacy, University of Camerino  Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-018-0079-0"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2016.02.006"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2017_1588"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25873"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190716102037"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02090-z"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.09744"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-011-1031-z"},{"key":"e_1_2_11_11_1","first-page":"2077","article-title":"Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist","volume":"23","author":"Fishman P","year":"2003","journal-title":"Anticancer Res"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.05.028"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.2503"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020187"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020164"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1000"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86921-9"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47328-w"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18935-1"},{"key":"e_1_2_11_21_1","first-page":"2823","article-title":"A3 adenosine receptor antagonist, truncated Thio\u2010Cl\u2010IB\u2010MECA, induces apoptosis in T24 human bladder cancer cells","volume":"30","author":"Kim H","year":"2010","journal-title":"Anticancer Res"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2016.10.013"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.118.115295"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22775"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2022.5086"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114103"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14344"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02012-7"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2024.104104"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7862430"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112945"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1012505"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1251100"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-1653"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020372"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14519"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.09.004"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.0829"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-019-0141-6"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13030291"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00169.2023"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030216"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.06.005"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-023-01516-8"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1891"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.616332"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0317-1"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1005271"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105773"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.05334"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-019-01346-4"}],"container-title":["FEBS Open Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/2211-5463.70024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:19:44Z","timestamp":1751588384000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1002\/2211-5463.70024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1002\/2211-5463.70024"],"URL":"https:\/\/doi.org\/10.1002\/2211-5463.70024","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/2211-5463.70024\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/2211-5463.70024\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/2211-5463.70024\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/2211-5463.70024\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/2211-5463.70024\/v2\/decision1","asserted-by":"object"}]},"ISSN":["2211-5463","2211-5463"],"issn-type":[{"value":"2211-5463","type":"print"},{"value":"2211-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"2024-11-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}